| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 723-728, Copyright © 1995 by Endocrine Society
ARTICLES |
SJ Silverberg, F Gartenberg, TP Jacobs, E Shane, E Siris, RB Staron and JP Bilezikian
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032.
A large number of patients with primary hyperparathyroidism today do not undergo parathyroidectomy. In this prospective study, we evaluated the effect of untreated disease on biochemical and bone densitometric indices. In 66 patients, seven annual measurements showed no change in serum calcium, phosphorus, PTH, vitamin D, or alkaline phosphatase; in urinary calcium, hydroxyproline or hydroxypyridinium cross-link excretion; or lumbar spine, femoral neck, and radial bone mineral density. The subset of postmenopausal women also showed no change in biochemical indices or bone density at any of the three sites. Twenty- four patients met guidelines for surgery as established by the NIH Consensus Conference, 1990. They differed from those who did not meet these guidelines only by being younger (50 +/- 3 vs. 62 +/- 2 yr; P = 0.0005) and by having higher urinary calcium excretion [7.7 +/- 0.9 vs. 5.4 +/- 0.3 mmol/L (310 +/- 37 vs. 215 +/- 14 mg/g creatinine); P < 0.01]. No longitudinal changes in biochemical profile or bone mineral density at any site were noted in this subgroup. Conservative management of patients with mild primary hyperparathyroidism does not lead to progression of disease, as reflected by biochemical indices. Bone density is maintained over 6 yr of observation at sites reflecting both cortical (radius) and cancellous (lumbar spine) bone.
This article has been cited by other articles:
 |
|
 |
|
  P. Chavassieux, E. Seeman, and P. D. Delmas Insights into Material and Structural Basis of Bone Fragility from Diseases Associated with Fractures: How Determinants of the Biomechanical Properties of Bone Are Compromised by Disease Endocr. Rev., April 1, 2007; 28(2): 151 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Strewler A 64-Year-Old Woman With Primary Hyperparathyroidism JAMA, April 13, 2005; 293(14): 1772 - 1779. [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Rao, E. R. Phillips, G. W. Divine, and G. B. Talpos Randomized Controlled Clinical Trial of Surgery Versus No Surgery in Patients with Mild Asymptomatic Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5415 - 5422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Silverberg and J. P. Bilezikian "Incipient" Primary Hyperparathyroidism: A "Forme Fruste" of an Old Disease J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5348 - 5352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Rubin and J. P. Bilezikian The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4033 - 4041. [Full Text] [PDF]
|
|
|
|
|
|
B. L. Riggs, S. Khosla, and L. J. Melton III Sex Steroids and the Construction and Conservation of the Adult Skeleton Endocr. Rev., June 1, 2002; 23(3): 279 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Orr-Walker, M. C. Evans, J. M. Clearwater, A. Horne, A. B. Grey, and I. R. Reid Effects of Hormone Replacement Therapy on Bone Mineral Density in Postmenopausal Women With Primary Hyperparathyroidism: Four-Year Follow-up and Comparison With Healthy Postmenopausal Women Arch Intern Med, July 24, 2000; 160(14): 2161 - 2166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nakaoka, T. Sugimoto, T. Kobayashi, T. Yamaguchi, A. Kobayashi, and K. Chihara Prediction of Bone Mass Change after Parathyroidectomy in Patients with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1901 - 1907. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. J. Silverberg, E. Shane, T. P. Jacobs, E. Siris, and J. P. Bilezikian A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery N. Engl. J. Med., October 21, 1999; 341(17): 1249 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Silverberg, J. P. Bilezikian, H. G. Bone, G. B. Talpos, M. J. Horwitz, and A. F. Stewart To Treat or Not To Treat: Conclusions from the NIH Consensus Conferencea J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2275 - 2278. [Full Text]
|
|
|
|
|
|
H. G. Bone Who Needs Parathyroid Surgery? The Case for Parathyroidectomy in Nonclassical Primary Hyperparathyroidismb J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2278 - 2282. [Full Text]
|
|
|
|
|
|
D. W. Dempster, M. Parisien, S. J. Silverberg, X.-G. Liang, M. Schnitzer, V. Shen, E. Shane, D. B. Kimmel, R. Recker, R. Lindsay, et al. On the Mechanism of Cancellous Bone Preservation in Postmenopausal Women with Mild Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1562 - 1566. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Duan, V. De Luca, and E. Seeman Parathyroid Hormone Deficiency and Excess: Similar Effects on Trabecular Bone But Differing Effects on Cortical Bone J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 718 - 722. [Abstract] [Full Text]
|
|
|
|
|
|
M. Abdelhadi and J. Nordenström Bone Mineral Recovery after Parathyroidectomy in Patients with Primary and Renal Hyperparathyroidism J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3845 - 3851. [Abstract] [Full Text]
|
|
|
|
|
|
S. J. Silverberg, H. G. Bone, T. B. Marriott, F. G. Locker, S. Thys-Jacobs, G. Dziem, S. Kaatz, E. L. Sanguinetti, and J. P. Bilezikian Short-Term Inhibition of Parathyroid Hormone Secretion by a Calcium-Receptor Agonist in Patients with Primary Hyperparathyroidism N. Engl. J. Med., November 20, 1997; 337(21): 1506 - 1511. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
